NCT06871267

Brief Summary

This research project aimed to develop a culturally appropriate Asian Inflammatory Bowel Disease Diet for the Malaysian population, based on the Crohn's disease exclusion diet (CDED). The study will be conducted in inflammatory bowel disease patients in University Malaya Medical Centre, which are ulcerative colitis and Crohn's disease patients. The objectives of this study are to assess the impact of diet in clinical outcome and gut microbiota changes in patients with inflammatory bowel disease (IBD). The study duration spans 24 weeks, during which comprehensive follow-ups will be conducted at 0, 6, 12, and 24 weeks, respectively. At each follow-up session, participants will be requested to provide stool and blood samples for meticulous assessment of clinical and biochemical responses.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
74

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 24, 2025

Completed
5 days until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 11, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2026

Completed
Last Updated

May 31, 2025

Status Verified

May 1, 2025

Enrollment Period

6 months

First QC Date

February 24, 2025

Last Update Submit

May 27, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • To improve the Asian Inflammatory Bowel Disease diet.

    Implementing improvised dietary guidance based on CDED is suitable for Asian settings to see patients' adherence (%) based on the diet adherence rating scale questionnaire.

    24 weeks

  • Number of Participants Achieving Clinical Response at Week 12

    Clinical response will be assessed based on Crohn's Disease Activity Index (CDAI) score. An improvement of clinical response is defined as \<150 CDAI score at week 12.

    12 weeks

Secondary Outcomes (3)

  • Change in Fecal Calprotectin Concentration from Baseline to Post-Intervention

    12 weeks

  • Changes in Gut Microbiota Composition Over Time (Baseline, Week 6, Week 12, Week 24)

    Baseline, Week 6, Week 12, Week 24

  • Differential Distribution of Gut Microbiota Between Control and Intervention Groups at Weeks 6, 12, and 24

    Week 6, Week 12, Week 24

Study Arms (2)

General Healthy Diet Group

ACTIVE COMPARATOR

Participants in this group will follow the quarter-quarter-half plate diet based on the Malaysian Healthy Plate guideline.

Behavioral: General Healthy Diet

Crohn's Disease Exclusion Diet (CDED) Group

EXPERIMENTAL

Participants in this group will follow the Crohn's Disease Exclusion Diet (CDED), which consists of three phases with specific dietary restrictions.

Behavioral: Crohn's Disease Exclusion Diet (CDED)

Interventions

Participants will follow the quarter-quarter-half plate diet as per the Malaysian Healthy Plate guideline.

General Healthy Diet Group

Participants will follow the Crohn's Disease Exclusion Diet (CDED), which consists of three phases with specific dietary restrictions.

Crohn's Disease Exclusion Diet (CDED) Group

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Confirmed diagnosis of Crohn's disease according to established clinical, endoscopic, and histological criteria.
  • Mild to moderate diseases (150 to 220 points).
  • Written informed consent obtained.

You may not qualify if:

  • Presence of stoma.
  • Surgery within 6 months prior to randomization.
  • Patient on exclusive enteral nutrition (EEN).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universiti Malaya Medical Centre

Kuala Lumpur, Petaling Jaya, 50603, Malaysia

RECRUITING

MeSH Terms

Conditions

Crohn Disease

Condition Hierarchy (Ancestors)

Inflammatory Bowel DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal Diseases

Central Study Contacts

Ida Normiha Hilmi, MRCP PhD

CONTACT

Nazihah Wafi, BMedSci

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 24, 2025

First Posted

March 11, 2025

Study Start

March 1, 2025

Primary Completion

September 10, 2025

Study Completion

February 10, 2026

Last Updated

May 31, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations